taxonomy (2)
protein (2)
source (2)
structure (29)
composition (28)
disease (3)
reference (3)
site (2)
peptide (0)
- Alpha-fetoprotein / Homo sapiens P02771
- Uncharacterized protein from Ascitic fluid / Mus musculus
Protein
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(a1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc+"+ 2 x NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(a1-3)"
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(b1-3) + 2 x NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc+"+ Gal(b1-2)GlcNAc(b1-3) + 3 x NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc+"+ 2 x Gal(b1-4)GlcNAc(b1-3) + 2 x NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc+"+ 2 x Gal(b1-4)GlcNAc(b1-3) + 3 x NeuAc"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / No-core / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)Man(b1-4)GlcNAc
- N-Linked / No-core / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-?)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-3)Man(b1-4)GlcNAc
- N-Linked / No-core / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)Man(b1-4)GlcNAc
Reported structure
- Hex:3 HexNAc:2 NeuAc:1 (avg mass : 1202.0904 )
- Hex:4 HexNAc:2 NeuAc:1 (avg mass : 1364.2328 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:3 NeuAc:2 (avg mass : 1858.6857 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:3 NeuAc:2 (avg mass : 2020.8281 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:4 (avg mass : 1803.6497 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 NeuAc:2 (avg mass : 2386.1655 )
- Hex:6 HexNAc:4 NeuAc:3 (avg mass : 2677.4234 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:7 HexNAc:4 (avg mass : 1965.7921 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
- Hex:7 HexNAc:5 NeuAc:2 (avg mass : 2751.5029 )
- Hex:7 HexNAc:5 NeuAc:3 (avg mass : 3042.7608 )
- Hex:7 HexNAc:5 dHex:1 (avg mass : 2315.1301 )
- Hex:8 HexNAc:5 dHex:1 (avg mass : 2477.2725 )
- Hex:8 HexNAc:6 NeuAc:2 (avg mass : 3116.8403 )
- Hex:8 HexNAc:6 NeuAc:3 (avg mass : 3408.0982 )
- Hex:8 HexNAc:7 (avg mass : 2737.5195 )
Composition
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Lymphoma, Lymphoblastic (DOID:0080147)
- Sialidosis, severe infantile with abdominal ascites (DOID:3343)
Disease
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
- Severe infantile sialidosis--the characteristics of oligosaccharides isolated from the urine and the abdominal ascites. (1992 - Nakamura Y, Takahashi Y, Yamaguchi S, Omiya S, Orii T, Yara A, Gushiken M) / Status : Reviewed
- Cell type and maturation stage-dependent polymorphism of N-linked oligosaccharides on murine lymphocytes and lymphoma cells. (1991 - Yoshida T, Takahashi N, Nakashima I) / Status : Reviewed
Reference
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
Reported glycosite
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1364.2328)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Lymphoma, Lymphoblastic (DOID:0080147)
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
- Cell type and maturation stage-dependent polymorphism of N-linked oligosaccharides on murine lymphocytes and lymphoma cells. (1991 - Yoshida T, Takahashi N, Nakashima I) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1729.5702)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Lymphoma, Lymphoblastic (DOID:0080147)
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
- Cell type and maturation stage-dependent polymorphism of N-linked oligosaccharides on murine lymphocytes and lymphoma cells. (1991 - Yoshida T, Takahashi N, Nakashima I) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1803.6497)
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1844.7023)
- Ascitic fluid (UBERON_0007795)
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1965.7921)
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1990.8453)
- Ascitic fluid (UBERON_0007795)
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2006.8447)
- Ascitic fluid (UBERON_0007795)
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2020.8281)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / Complex
(avg mass : 2094.9076)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / Complex
(avg mass : 2111.9351)
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Carcinoma, Gallbladder which metastasises to the liver (DOID:4948)
- Lymphoma, Lymphoblastic (DOID:0080147)
- Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. (1993 - Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H) / Status : Reviewed
- Cell type and maturation stage-dependent polymorphism of N-linked oligosaccharides on murine lymphocytes and lymphoma cells. (1991 - Yoshida T, Takahashi N, Nakashima I) / Status : Reviewed
-
Alpha-fetoprotein / Homo sapiens
- Undefined site
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2315.1301)
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2386.1655)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / Complex
(avg mass : 2477.2725)
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2677.4234)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / Complex
(avg mass : 2737.5195)
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2751.5029)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / Complex
(avg mass : 3042.7608)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / Complex
(avg mass : 3116.8403)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / Complex
(avg mass : 3408.0982)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / High-Mannose
(avg mass : 1235.1173)
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1397.2597)
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / No-core
(avg mass : 1202.0904)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / No-core
(avg mass : 1567.4278)
Released - Ascitic fluid (UBERON_0007795)
-
- N-Linked / No-core
(avg mass : 1858.6857)
Released - Ascitic fluid (UBERON_0007795)
Source
Reported glycosite
- N-Linked / No-core
(avg mass : 1858.6857)
Source
Reported glycosite
- N-Linked / No-core
(avg mass : 1567.4278)
Source
Reported glycosite
- N-Linked / No-core
(avg mass : 1202.0904)
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1397.2597)
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1235.1173)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3408.0982)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3116.8403)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3042.7608)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2751.5029)
Reported glycosite
- N-Linked / Complex
(avg mass : 2737.5195)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2677.4234)
Reported glycosite
- N-Linked / Complex
(avg mass : 2477.2725)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2386.1655)
Reported glycosite
- N-Linked / Complex
(avg mass : 2315.1301)
Reported glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Reported glycosite
- N-Linked / Complex
(avg mass : 2111.9351)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2094.9076)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2020.8281)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1990.8453)
Reported glycosite
- N-Linked / Complex
(avg mass : 1965.7921)
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1844.7023)
Reported glycosite
- N-Linked / Complex
(avg mass : 1803.6497)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1729.5702)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1364.2328)
